LEUVEN, BELGIUM.
Belgian researchers have released the results of a major
study aimed at determining the long-term effects of fish
oil supplementation in rheumatoid arthritis patients.
Sixty patients completed the year-long, double-blind,
randomized study. The participants were divided into 3
groups with 1 group receiving a daily supplement of 6
capsules containing 1 gram of olive oil each (placebo);
another group receiving 3 olive oil capsules plus 3 fish
oil capsules (containing 1 gram of fish oil each); and
the third group receiving 6 fish oil capsules daily
(corresponding to 2.6 grams/day of omega-3 fatty acid).
All patients continued on their regular arthritis
medications.
Three months into the
study it became clear that the patients on fish oil
alone had improved considerably when compared to the
other 2 groups and this improvement became even more
pronounced after 12 months of supplementation.
Fifty-three per cent of the patients in the fish oil
group showed significant overall (global) improvement as
compared to 10% in the placebo group and 33% in the fish
oil plus olive oil group. Forty-seven per cent of the
patients in the fish oil group were also able to reduce
their intake of NSAIDs and disease-modifying
anti-rheumatic drugs as compared to 15% in the placebo
group and 29% in the olive oil plus fish oil group. The
researchers conclude that long-term supplementation with
fish oils benefits rheumatoid arthritis patients
significantly and may lessen their need for NSAIDs and
other RA medications.
Geusens, Piet, et al.
Long-term effect of omega-3 fatty acid supplementation
in active rheumatoid arthritis. Arthritis & Rheumatism,
Vol. 37, June 1994, pp. 824-29
Borage and
Fish Oils Go Together
JACKSONVILLE, FLORIDA.
Supplementation with gamma-linolenic acid (GLA) found in
borage and evening primrose oils reduces the symptoms of
chronic inflammatory diseases such as rheumatoid
arthritis and atopic dermatitis. It is believed that the
transformation of GLA to DGLA (dihomo-gamma- linolenic
acid) in the inflammatory cells (white blood cells)
helps dampen the inflammatory effects of AA (arachidonic
acid). Unfortunately, there is a fly in the ointment.
While GLA supplementation results in a decrease in AA in
the inflammatory cells it also causes, somewhat
paradoxically, a very significant increase in AA in the
blood serum itself. A high blood level of AA is
associated with an increased risk of blood clotting and
is a potent risk factor for heart disease.
Researchers at the Mayo
Clinic now report that the potentially harmful effects
of GLA supplementation can be eliminated by simultaneous
supplementation with fish oil. Their small clinical
trial involved a control group of 2 healthy men and 2
healthy women who consumed a controlled diet while
supplementing with 3 grams/day of GLA (5 capsules of
borage oil morning and evening). The active treatment
group (5 women and 7 men) followed the same protocol
with the addition of 3 grams/day of EPA (eicosapentaenoic
acid) taken in the form of 5 capsules of concentrated
fish oil (each capsule containing 600 mg of EPA and 280
mg of DHA (docosahexaenoic acid). After 3 weeks of
supplementation samples of white blood cells and samples
of blood serum were analyzed to determine fatty acid
profiles. Both groups experienced a marked increase in
beneficial DGLA in their white blood cells. The control
group (GLA supplementation only) also saw a significant
increase in detrimental AA in their blood serum, but no
such increase was observed in the group taking fish oil
as well.
The researchers conclude
that the detrimental effects of GLA supplementation can
be avoided by adding fish oils to the supplementation
regimen.
Barham, J. Brooke, et al.
Addition of eicosapentaenoic acid to gamma-linolenic
acid: supplemented diets prevent serum arachidonic acid
accumulation in humans. Journal of Nutrition, Vol. 130,
2000, pp. 1925-31
Fish Oils
Recommended For Rheumatoid Arthritis
NEWCASTLE, AUSTRALIA.
At least 13 published randomized, controlled clinical
trials have reported significant benefits of fish oil
supplementation in rheumatoid arthritis patients. Now
researchers at the University of Newcastle weight in
with the additional evidence to support these earlier
findings. Their 15- week study involved 50 patients who
had been diagnosed with rheumatoid arthritis. The
patients were all consuming a diet which contained less
than 10 grams/day of omega-6 fatty acids. These fats are
known to promote inflammation through their eicosanoid
metabolites. Half the patients were given fish oil
capsules to provide a daily intake of 40 mg/kg body
weight (about 2.8 grams for a 70 kg person); the other
half received placebo capsules containing 50/50
corn/olive oil. All subjects continued with their
regular diet and medications. About half the patients
dropped out during the experiment, mainly due to changes
in their medications. Complete clinical evaluations were
carried out at baseline, 4, 8 and 15 weeks.
There were no significant
changes after 4 or 8 weeks, but at the 15-week
evaluation major improvements were noted in the group
receiving fish oil. Particularly impressive were the
improvements in the duration of morning stiffness and
the overall assessment of disease activity (by both
patients and physicians). Significant improvements were
noted in 6 of the 9 evaluation parameters in the fish
oil group; no improvements were noted in the control
group. Only the total number of joints affected, the
erythrocyte sedimentation rate (ESR), and the C-reactive
protein level were unaffected by supplementation.
In an accompanying
editorial Drs. Cleland and James of the Royal Adelaide
Hospital emphasize the importance of maintaining a low
intake of omega-6 fatty acids in order to keep the ratio
of omega-6 to omega-3 as low as possible. They conclude
that "dietary fish oil supplements should now be
regarded as part of standard therapy for rheumatoid
arthritis".
Volker, Dianne, et al.
Efficacy of fish oil concentrate in the treatment of
rheumatoid arthritis. Journal of Rheumatology, Vol. 27,
October 2000, pp. 2343-46
Cleland, Leslie G. and
James, Michael J. Fish oil and rheumatoid arthritis:
antiinflammatory and collateral health benefits. Journal
of Rheumatology, Vol. 27, October 2000, pp. 2305-06
(editorial)